Categories AlphaGraphs, Other Industries

UnitedHealth might turn suitor for Tenet’s Conifer unit

UnitedHealth Group (UNH), a diversified healthcare company, has been named as a possible suitor in the sale of Tenet Healthcare’s (THC) Conifer unit. If a deal takes place between the two firms, analysts expect Tenet to value its wholly owned operating subsidiary, Conifer Health Solutions to about $2 billion.

In 2017, Tenet — under the pressure of its largest shareholder Glenview Capital Management — put its healthcare management subsidiary Conifer up for sale. In 2017, Confier accounted for 8% of the total sales. The sale of Conifer is a part of the company’s larger plan of restructuring that includes cutting workforce, divesting hospitals, breaking business segments and cut cost by $100 million by the end of this year.

According to the latest reports by the Wall Street Journal, the insurance giant is one of the companies that is aiming to acquire Tenet’s Conifer unit. There are no details on the other potential suitors. However, there is no certainty that the deal between UnitedHealth and Tenet will be consummated. If it does, Conifer would be a part of UnitedHealth’s fastest growing business Optum.

Related: UnitedHealth Group reports Q2 earnings above estimates

This week, UnitedHealth Group reported its Q2 earnings that topped analyst estimates. It posted a 12% growth in its revenues to $56.1 billion, generating profits of $2.98 per share. Adjusted EPS totaled $3.14 for the quarter. Both GAAP and adjusted EPS grew 28% year-over-year. Despite the strong results, the company’s stock is trading in the red. As of today, the company’s share price is down 0.95% to $252.96.

UnitedHealth Group Q2 Infographic


UnitedHealth second quarter 2018 earnings

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top